Evidence map›Paper›PMID 30486442›Full record

ArticleMolecules (Basel, Switzerland)2018

Novel PEGylated Liposomes Enhance Immunostimulating Activity of isRNA.

Tatyana Kabilova, Elena Shmendel, Daniil Gladkikh, Nina Morozova, Mikhail Maslov, Elena Chernolovskaya, Valentin Vlassov, Marina Zenkova

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. siRNA-MediatedInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Activation of Innate Immunity by Therapeutic Nucleic Acids.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tatyana KabilovaInstitute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentieva ave. 8, Novosibirsk 630090, Russia. kabilova@niboch.nsc.ru.
Elena ShmendelInstitute of Fine Chemical Technologies, Moscow Technological University, Vernadskogo ave. 86, Moscow 119571, Russia. shmelka_87@mail.ru.
Daniil GladkikhInstitute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentieva ave. 8, Novosibirsk 630090, Russia. medulla35@gmail.com.ORCID 0000-0003-3736-0803
Nina MorozovaInstitute of Fine Chemical Technologies, Moscow Technological University, Vernadskogo ave. 86, Moscow 119571, Russia. ngmoroz@mail.ru.
Mikhail MaslovInstitute of Fine Chemical Technologies, Moscow Technological University, Vernadskogo ave. 86, Moscow 119571, Russia. mamaslov@mail.ru.ORCID 0000-0002-5372-1325
Elena ChernolovskayaInstitute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentieva ave. 8, Novosibirsk 630090, Russia. elena_ch@niboch.nsc.ru.
Valentin VlassovInstitute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentieva ave. 8, Novosibirsk 630090, Russia. vvlassov@mail.ru.
Marina ZenkovaInstitute of Chemical Biology and Fundamental Medicine SB RAS, Lavrentieva ave. 8, Novosibirsk 630090, Russia. marzen@niboch.nsc.ru.
Institute of Chemical Biology and Fundamental Medicine · RUMoscow State University of Fine Chemical Technologies · RU

Funding

Russian Science Foundation 16-15-10105
6 · The paper itself

Abstract

The performance of cationic liposomes for delivery of therapeutic nucleic acids in vivo can be improved and specifically tailored to certain types of cargo and target cells by incorporation of PEG-containing lipoconjugates in the cationic liposome's composition. Here, we report on the synthesis of novel PEG-containing lipoconjugates with molecular masses of PEG 800, 1500 and 2000 Da. PEG-containing lipoconjugates were used as one of the components in liposome preparation with the polycationic amphiphile 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetra-azahexacosan tetrahydrochloride (2X3) and the lipid-helper dioleoylphosphatidylethanolamine (DOPE). We demonstrate that increasing the length of the PEG chain reduces the transfection activity of liposomes in vitro, but improves the biodistribution, increases the circulation time in the bloodstream and enhances the interferon-inducing activity of immunostimulating RNA in vivo.

Indexed as

Adjuvants, ImmunologicPhosphatidylethanolaminesPolyethylene GlycolsRNAAnimalsCricetinaeHEK293 CellsHumansLiposomesMiceMice, Inbred CBAAdjuvants, Immunologicdioleoyl phosphatidylethanolamineLiposomesPhosphatidylethanolaminesPolyethylene GlycolsRNAbiodistributioncationic liposomesimmunostimulating RNAnon-viral delivery systemPEG-containing lipoconjugatestransfection

Identifiers

PMID30486442
PMCPMC6321517
OpenAlexW2902418737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.